268 related articles for article (PubMed ID: 23408941)
1. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
Mukhopadhyay P; Lakshmanan I; Ponnusamy MP; Chakraborty S; Jain M; Pai P; Smith LM; Lele SM; Batra SK
PLoS One; 2013; 8(2):e54455. PubMed ID: 23408941
[TBL] [Abstract][Full Text] [Related]
2. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
Ponnusamy MP; Lakshmanan I; Jain M; Das S; Chakraborty S; Dey P; Batra SK
Oncogene; 2010 Oct; 29(42):5741-54. PubMed ID: 20697346
[TBL] [Abstract][Full Text] [Related]
3. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.
Workman HC; Miller JK; Ingalla EQ; Kaur RP; Yamamoto DI; Beckett LA; Young LJ; Cardiff RD; Borowsky AD; Carraway KL; Sweeney C; Carraway KL
Breast Cancer Res; 2009; 11(5):R70. PubMed ID: 19761616
[TBL] [Abstract][Full Text] [Related]
4. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
7. The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3.
Funes M; Miller JK; Lai C; Carraway KL; Sweeney C
J Biol Chem; 2006 Jul; 281(28):19310-9. PubMed ID: 16690615
[TBL] [Abstract][Full Text] [Related]
8. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract][Full Text] [Related]
9. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
Lakshmanan I; Seshacharyulu P; Haridas D; Rachagani S; Gupta S; Joshi S; Guda C; Yan Y; Jain M; Ganti AK; Ponnusamy MP; Batra SK
Oncotarget; 2015 Aug; 6(25):21085-99. PubMed ID: 26035354
[TBL] [Abstract][Full Text] [Related]
10. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity.
Kozloski GA; Carraway CA; Carraway KL
J Cell Physiol; 2010 Sep; 224(3):649-57. PubMed ID: 20432461
[TBL] [Abstract][Full Text] [Related]
12. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
[TBL] [Abstract][Full Text] [Related]
13. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1.
Rachagani S; Macha MA; Ponnusamy MP; Haridas D; Kaur S; Jain M; Batra SK
Carcinogenesis; 2012 Oct; 33(10):1953-64. PubMed ID: 22791819
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
15. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways.
Jonckheere N; Skrypek N; Merlin J; Dessein AF; Dumont P; Leteurtre E; Harris A; Desseyn JL; Susini C; Frénois F; Van Seuningen I
PLoS One; 2012; 7(2):e32232. PubMed ID: 22393391
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
17. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.
Workman HC; Sweeney C; Carraway KL
Cancer Res; 2009 Apr; 69(7):2845-52. PubMed ID: 19293191
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
[TBL] [Abstract][Full Text] [Related]
19. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
20. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]